Author

Vicki Segro

Observed names: Segro, Vicki, VICKI SEGRO

Observed institutions: Emory University, Colorado Neurological Institute, University of Rochester

OpenAlex ID: A5081166638

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

2012 · J.-M. Lee, E.M. Ramos, et al. · Neurology · 382

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

2017 · Scott A. Schobel, Giuseppe Palermo, et al. · Neurology · 155

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

2023 · Erin Furr Stimming, Daniel O Claassen, et al. · The Lancet Neurology · 67

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

2022 · Samuel Frank, Claudia Testa, et al. · CNS Drugs · 33

Movement Disorders Associated With Aripiprazole Use: a Case Series

2009 · DEBORAH A. HALL, PINKY AGARWAL, et al. · International Journal of Neuroscience · 26

Works count: 6

Citation count: 663

H-index: 5

I10-index: 5